1 October 2022 - From 1 October, Australians with advanced or metastatic gastro-oesophageal cancers will have access to new treatment through the PBS.
The Australian Government will expand the PBS listing of nivolumab (Opdivo) for the treatment of advanced or metastatic gastro-oesophageal cancers.